Canaccord Genuity analyst Susan Anderson maintained a Buy rating on Olaplex Holdings yesterday and set a price target of $2.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Susan Anderson’s rating is based on Olaplex Holdings’ strong performance in the third quarter of 2025, where the company exceeded sales expectations despite a challenging market environment. The management’s strategic focus on generating brand demand, fostering innovation, and executing with excellence has shown promising results, leading to increased marketing efforts and early signs of consumer purchasing conversion.
Furthermore, Olaplex’s commitment to science-backed innovation, as evidenced by the launch of six new SKUs this year, is expected to drive future growth. The acquisition of Purvala, a biotech company, is anticipated to accelerate innovation by adding more science-backed intellectual property to Olaplex’s portfolio. The resilience of the prestige beauty category, even amidst economic volatility, is likely to benefit Olaplex, supporting Anderson’s Buy rating.
Based on the recent corporate insider activity of 23 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OLPX in relation to earlier this year.